Pfizer Inc.PFIZER INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.
Antonym: dec. . (New York) said it is expanding a partnership with RNA RNA: see nucleic acid.
in full ribonucleic acid
One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic drug developer Santaris Pharma A/S (Horsholm DNK) in a deal that could be worth more than $600 million. Pfizer said it will pay the Danish company $14 million upfront for the drug candidates, which are designed to target RNA. Santaris could get up to $600 million in milestone payments, plus royalties if any drugs from the collaboration are approved. Pfizer said Santaris will deliver drugs for up to 10 RNA targets. RNA is genetic material that's produced inside cells by DNA DNA: see nucleic acid.
or deoxyribonucleic acid
One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. . RNA makes proteins that control cellular operations, including disease processes. The deal expands an agreement between Santaris and Wyeth, which is now part of Pfizer. In January 2009, Wyeth agreed to pay Santaris $7 million upfront and make a $10 million investment in the company. Santaris could also receive milestone payments as part of that deal. Pfizer said some programs from that partnership have been advanced and reached early milestones.
Shares of Pfizer closed the week up 83 cents, or 5%, at $18.34.